An open-label, single- & multiple-dose study to investigate the pharmacokinetics of sitagliptin 100 mg in healthy Chinese adult subjects

Trial Profile

An open-label, single- & multiple-dose study to investigate the pharmacokinetics of sitagliptin 100 mg in healthy Chinese adult subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Apr 2014

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Merck & Co
  • Most Recent Events

    • 30 Sep 2008 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.
    • 30 Sep 2008 Actual patient number (16) added as reported by ClinicalTrials.gov.
    • 30 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top